EUGENIE S KLEINERMAN to Macrophage Activation
This is a "connection" page, showing publications EUGENIE S KLEINERMAN has written about Macrophage Activation.
Connection Strength
0.731
-
Therapy of cancer metastasis by systemic activation of macrophages: from the bench to the clinic. Res Immunol. 1993 May; 144(4):284-7; discussion 294-8.
Score: 0.109
-
Influence of chemotherapy administration on monocyte activation by liposomal muramyl tripeptide phosphatidylethanolamine in children with osteosarcoma. J Clin Oncol. 1991 Feb; 9(2):259-67.
Score: 0.093
-
Activation of monocyte-mediated tumoricidal activity in patients with acquired immunodeficiency syndrome. J Clin Oncol. 1985 Jul; 3(7):1005-12.
Score: 0.063
-
Intracellular activation of human and rodent macrophages by human lymphokines encapsulated in liposomes. J Leukoc Biol. 1985 May; 37(5):571-84.
Score: 0.063
-
Constitutive production and release of a lymphokine with macrophage-activating factor activity distinct from gamma-interferon by a human T-cell leukemia virus-positive cell line. Cancer Res. 1984 Oct; 44(10):4470-5.
Score: 0.060
-
Lymphokine-activated human blood monocytes destroy tumor cells but not normal cells under cocultivation conditions. J Clin Oncol. 1984 Aug; 2(8):937-43.
Score: 0.060
-
Tumoricidal activity of human monocytes: evidence for cytolytic function distinct from that of NK cells. J Immunol. 1984 Jul; 133(1):4-6.
Score: 0.059
-
Activation of tumoricidal properties in human blood monocytes by liposomes containing lipophilic muramyl tripeptide. Cancer Res. 1983 May; 43(5):2010-4.
Score: 0.055
-
Biologic therapy for osteosarcoma using liposome-encapsulated muramyl tripeptide. Hematol Oncol Clin North Am. 1995 Aug; 9(4):927-38.
Score: 0.032
-
Liposome-encapsulated muramyl tripeptide: a new biologic response modifier for the treatment of osteosarcoma. Cancer Treat Res. 1993; 62:101-7.
Score: 0.027
-
Macrophages and cancer. Cancer Metastasis Rev. 1990 Feb; 8(4):319-51.
Score: 0.022
-
Activated human blood monocytes trigger the antitumor activity of blood polymorphonuclear cells. Lymphokine Res. 1989; 8(4):427-37.
Score: 0.020
-
Abrogation of species specificity for activation of tumoricidal properties in macrophages by recombinant mouse or human interferon-gamma encapsulated in liposomes. J Immunol. 1985 Dec; 135(6):4289-96.
Score: 0.016
-
Human monocyte-mediated cytotoxicity against herpes simplex virus-infected cells: activation of cytotoxic monocytes by free and liposome-encapsulated lymphokines. J Leukoc Biol. 1985 Apr; 37(4):461-72.
Score: 0.016
-
Ultrastructural studies of the interaction between liposome-activated human blood monocytes and allogeneic tumor cells in vitro. Am J Pathol. 1983 Jul; 112(1):101-11.
Score: 0.014
-
Production and utilization of human lymphokines containing macrophage-activating factor (MAF) activity. Lymphokine Res. 1983; 2(1):7-12.
Score: 0.013
-
Human recombinant macrophage colony stimulating factor activates murine Kupffer cells to a cytotoxic state. Lymphokine Res. 1990; 9(3):355-63.
Score: 0.005
-
Synergism between human recombinant gamma-interferon and muramyl dipeptide encapsulated in liposomes for activation of antitumor properties in human blood monocytes. Cancer Res. 1985 Dec; 45(12 Pt 1):6188-93.
Score: 0.004